Within the spectrum of mutations identified in HNSCC, the phosphoinositide 3-kinase (PI3K)–AKT–mTOR pathway is the most frequently mutated (30.5%), and multiple mutations in this pathway always lead to a stage IV cancer [44]. This evidence concerns the gene PIK3CA and head and neck squamous cell carcinoma.